Switching From Natalizumab To Immune Reconstitution Therapies In Patients With Multiple Sclerosis

被引:0
|
作者
Matos, Sara [1 ]
Cunha, Carolina [1 ]
Bernardes, Catarina [1 ]
Cardoso, Joao [2 ]
Campelo, Isabel [2 ]
Feio, Jose [2 ]
Batista, Sonia [1 ,3 ]
Nunes, Carla [1 ]
Macario, Maria do Carmo [1 ,3 ]
Sousa, Livia Maria [1 ,3 ]
Correia, Ines [1 ,3 ]
机构
[1] Coimbra Univ Hosp Ctr, Neurol, Coimbra, Portugal
[2] Coimbra Univ Hosp Ctr, Hosp Pharm, Coimbra, Portugal
[3] Coimbra Univ, Fac Med, Coimbra, Portugal
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P1464/1365
引用
收藏
页码:931 / 931
页数:1
相关论文
共 50 条
  • [31] Clinically silent PML and prolonged immune reconstitution inflammatory syndrome in a patient with multiple sclerosis treated with natalizumab
    Blinkenberg, Morten
    Sellebjerg, Finn
    Leffers, Anne-Mette
    Madsen, Camilla Gobel
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (09) : 1226 - 1229
  • [32] Comparative efficacy of switching to natalizumab in active multiple sclerosis
    Spelman, Timothy
    Kalincik, Tomas
    Zhang, Annie
    Pellegrini, Fabio
    Wiendl, Heinz
    Kappos, Ludwig
    Tsvetkova, Larisa
    Belachew, Shibeshih
    Hyde, Robert
    Verheul, Freek
    Grand-Maison, Francois
    Izquierdo, Guillermo
    Grammond, Pierre
    Duquette, Pierre
    Lugaresi, Alessandra
    Lechner-Scott, Jeannette
    Oreja-Guevara, Celia
    Hupperts, Raymond
    Petersen, Thor
    Barnett, Michael
    Trojano, Maria
    Butzkueven, Helmut
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (04): : 373 - 387
  • [33] The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica
    Brod, Staley A.
    AUTOIMMUNITY REVIEWS, 2022, 21 (10)
  • [34] Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
    Khoy, Kathy
    Mariotte, Delphine
    Defer, Gilles
    Petit, Gautier
    Toutirais, Olivier
    Le Mauff, Brigitte
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [35] Characteristics of Patients Switching from Anti-CD20 Therapy to Natalizumab in the Treatment of Multiple Sclerosis
    Vollmer, Brandi
    Nair, Kavita
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2019, 92 (15)
  • [36] Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
    Toorop, Alyssa A.
    van Kempen, Zoe L. E.
    Steenhuis, Maurice
    Nielsen, Jessica
    Sinnige, L. G. F.
    van Dijk, Gert
    Roosendaal, Christiaan M.
    Arnoldus, Edo P. J.
    Hoitsma, Elske
    Lissenberg-Witte, Birgit, I
    de Jong, Brigit A.
    van Oosten, Bob W.
    Strijbis, Eva M. M.
    Uitdehaag, Bernard M. J.
    Rispens, Theo
    Killestein, Joep
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (06): : 482 - 486
  • [37] Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
    Fragoso, Yara Dadalti
    Alves-Leon, Soniza Vieira
    Becker, Jefferson
    Bidin Brooks, Joseph Bruno
    Correa, Eber Castro
    Damasceno, Alfredo
    da Gama, Paulo Diniz
    da Gama, Rodrigo Assad
    da Cunha Matta, Andre Palma
    Maciel, Ernane Pires
    d'Avila Winckler, Thereza Cristina
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2016, 74 (08) : 650 - 652
  • [38] Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod
    Jander, Sebastian
    Turowski, Bernd
    Kieseier, Bernd C.
    Hartung, Hans-Peter
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1650 - 1652
  • [39] Use of Natalizumab in Multiple Sclerosis Patients
    O'Connor, Paul W.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2010, 37 (01) : 98 - 104
  • [40] Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
    Schroeder, Alexandra
    Lee, De-Hyung
    Hellwig, Kerstin
    Lukas, Carsten
    Linker, Ralf A.
    Gold, Ralf
    ARCHIVES OF NEUROLOGY, 2010, 67 (11) : 1391 - 1394